Gyeonggi-do, South Korea

Dongkyu Kim

USPTO Granted Patents = 2 

 


Average Co-Inventor Count = 10.5

ph-index = 1


Location History:

  • Gyeonggi-do, KR (2022)
  • Suwon-si, KR (2024)

Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dongkyu Kim: Innovator in Pharmaceutical Chemistry

Introduction

Dongkyu Kim is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 2 patents to his name, Kim's work focuses on innovative solutions for treating various diseases.

Latest Patents

Kim's latest patents include groundbreaking research on N-(isopropyl-triazolyl)pyridinyl)-heteroaryl-carboxamide derivatives. This patent details a preparation method and the use of these derivatives for preventing or treating ASK-1 mediated diseases. His second patent involves a heterocyclic compound that acts as a protein kinase inhibitor. This invention is crucial for developing treatments for diseases related to protein kinases, including cancer and autoimmune disorders.

Career Highlights

Dongkyu Kim is currently associated with Hk Inno.n Corporation, where he continues to push the boundaries of pharmaceutical innovation. His work has garnered attention for its potential impact on healthcare and disease management.

Collaborations

Kim collaborates with talented colleagues, including Seungin Kim and Jaeho Yoo, to advance research and development in their field. Their combined expertise fosters a dynamic environment for innovation.

Conclusion

Dongkyu Kim's contributions to pharmaceutical chemistry exemplify the spirit of innovation in the medical field. His patents reflect a commitment to developing effective treatments for complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…